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Abstract
Background: Obstructive Sleep Apnoea (OSA) is a risk factor for cardiovascular disease (CVD) and Type 2 diabetes
(T2D). Observational studies suggested that OSA treatment might reduce CVD and T2D but RCTs failed to support
these observations in part due to poor adherence to continuous positive airway pressure (CPAP). Physical activity
(PA) has been shown to have favourable impact on CVD and the risk of T2D independent of its impact on weight
and therefore might provide additional health gains to patients with OSA, whether or not adherent to CPAP.
Methods: The main aim of this study was to explore the feasibility of providing a 12-week PA intervention to
adults aged over 50 with OSA. The secondary aim was to assess the impact of the PA intervention on OSA severity.
Patients with moderate-severe OSA (apnoea hypopnea index (AHI) ≥ 15 events/hour (based on overnight
ApneaLink™) were recruited in response to posters displayed in workplaces. A 12-week daily PA intervention was
delivered in participant’s home setting and PA was monitored via text and validated by objective PA measures
(GT3X accelerometers).
Results: The intervention was feasible as all 10 patients (8 males, mean (SD) age 57.3 (6.01)) completed the
intervention and PA increased across the 12-weeks. The duration of PA increased from baseline (113.1 min (64.69)
per week to study-end following the intervention (248.4 min (148.31) (p = 0.02). Perceived Exertion (RPE) (physical
effort) increased significantly between baseline (M = 10.7 (1.94)) to end of intervention (M = 13.8, (1.56) (p < 0.001).
The intervention had no significant impact on weight or composition. Following the intervention, there was a
statistically non-significant a reduction in AHI from baseline to study end (22.3 (7.35) vs. 15.8 (7.48); p = 0.09).
Conclusion: It is feasible to deliver a PA intervention to adults aged over 50 with OSA. The intervention resulted in
improved PA and AHI levels somewhat and seemingly independent of weight changes. Future trials need to
examine whether PA can reduce the burden of OSA associated comorbidities.
Trial registration: CTN: ISRCTN11016312 Retrospectively Registered 21/07/20.
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Background
Obstructive Sleep Apnoea (OSA) is a common disorder
that is currently estimated to affect approximately one
billion people worldwide [1]; with high prevalence in
many countries such as the U.S. (34% men and 17%
women), and Switzerland (50% men and 23% women)
among others [1]. OSA prevalence increases with age
until up to 60 years old [2], hence, many middle-aged
men and women are at increased risk of developing
OSA [3–5]. OSA is characterized by instability in the
upper airways (UAs) during sleep leading to recurrent
episodes of the UA obstruction [3]. These repeated
obstructions are associated with recurrent episodes of
oxygen desaturation/reoxygenation, cyclical changes in
blood pressure (BP), and heart rate, and increased
sympathetic activity and intrathoracic pressure, brief
microarousals and changes to sleep architecture, such as
the loss of REM and slow wave sleep [6]. OSA is associ-
ated with several comorbidities including increased risk
of cardiovascular disease (CVD) [7], Type-2 Diabetes
(T2D) and its microvascular complications [8–11], and
hypertension [12], and thus, has serious implications for
health and wellbeing across the lifespan.
Currently, the gold standard treatment for OSA is
continuous positive airway pressure (CPAP) [13].
Recently, it has been suggested that PA could be used as
an adjunctive to CPAP [14]. Observational studies have
shown the potential benefits of CPAP, which include
protection from heart failure (HF), T2D and CVD.
However, interventional studies have demonstrated that
CPAP, either with or without lifestyle advice, does not
protect against CVD [15] Thus, the potential clinical
benefits of CPAP use in this respect are questionable
and that PA may be a viable management tool for
reducing the risk of CVD and the severity of OSA.
Additionally, overall adherence to CPAP is often poor
due to discomfort with the mask and the general intru-
sion of the machine during sleep time amongst other
factors [16–18].
Although obesity is the main risk factor for OSA [19],
the lack of regular physical activity (PA) (30 min of
moderate to vigorous intensity, 5 days per week) also in-
creased the risk of OSA development [20–22]. As such,
it is plausible that PA might play an important role in
the pathogenesis and management of patients with OSA.
In addition to the potential direct benefits of PA on
OSA; PA and active lifestyle have been shown to reduce
CVD and T2D, independent of weight loss [23],
although whether this remains true in patients with
OSA remains unknown. Furthermore, cardiorespiratory
fitness has been shown to independently determine
health status [24].
We hypothesized that PA can improve cardiorespira-
tory fitness and improve OSA severity possibly via
facilitating upper airway adaption and rostral fluid shift
[25, 26]. Hence we conducted a study to assess the feasi-
bility of conducting a 12-week PA intervention in adults
aged 50 years and above with OSA. The secondary aim
was to assess the impact of the PA intervention on the
severity of OSA based on AHI).
Methods
Aim, design and setting
An uncontrolled feasibility single arm trial to deliver a
12-week PA intervention to a group of adults aged 50
years and over in participants’ home setting.
Participants
Participants were recruited via poster placed in work-
places and around local villages by the principal investi-
gator. The aim was to recruit 30 participants [27] as this
was a feasibility trial, so no formal power calculation was
made.
Inclusion criteria: 1. Adult manual workers (e.g. con-
struction, prison service) an underserved population in
this area of research. Older manual workers are known
to have low levels of leisure time physical activity and
OSA might impact longevity in the workplace, who were
employed for at least three months before the start of
the study, 2. had no previous diagnosis or treatment for
obstructive sleep apnoea (OSA) and were willing to be
screened for OSA and to participate in a 12-week phys-
ical activity (PA) intervention were eligible for the study.
The diagnosis of OSA was made using an ApneaLink™
device for one night and only those with AHI > 15
events/hour were invited to participate in the study [28].
Exclusion criteria included those younger than 50 or
older than 69 years old, unemployed or in employment
less than three months at commencement of study, had
history of chest pain during exercise or heart trouble, or
with a diagnosis of and currently undergoing treatment
for OSA. The University of Birmingham Science, Tech-
nology, Engineering and Mathematics ethics committee
approved the study (ERN_16–1326). All study partici-




The short form International Physical Activity Question-
naire (IPAQ) was used to measure habitual levels of
physical activity over the last seven days. The IPAQ
short form has been tested in 12 countries and has been
shown to produce good repeatable (75%) and reliable
data in middle aged employed samples [29] with median
internal consistencies of α = .80. Concurrent validity and
criterion validity have been supported; the scale can cor-
rectly classify low, moderate and high intensity activity
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[29]. The Cronbach’s alpha for internal consistency in
the present study was α = .77.
Objective physical activity
GT3X accelerometers (ActiGraph, Pensacola, FL, USA)
were used to validate subjective reports of PA and intensity.
The GTX3 has demonstrated high intra and inter-
instrument reliability with an intra-class correlation coeffi-
cient for activity counts of 0.97 [30]. The accelerometer was
worn as a belt on the right hip and collected motion data as
suggested by [31]. Activity counts were produced as a result
of the summed acceleration measured in the duration of
collection over seven days and represented a measure of ac-
tivity over time. Cut-points of < 1951, 1952–5724, > 5725
for light, moderate and vigorous intensity respectively, were
used to determine levels of low, moderate and vigorous in-
tensity physical activity [31, 32].
Increase in daily physical activity
Borg’s Rating of Perceived Exertion (RPE) scale was used
to assess physical activity intensity as perceived by par-
ticipants. Borg’s RPE is an affordable and reliable
method of measuring subjective perceived effort during
exercise and has been demonstrated as a valid measure
of intensity relating to heart rate [33].
Anthropometric measures
Height and weight were measured before the interven-
tion commenced to calculate body mass index (BMI)
(kg/m2). Electronic scales with bioelectrical impedance
analysis (Salter Ultra Slim Glass Analyser scales, model
9141, HoMedics Group Ltd., Kent, UK) were used to
measure weight and body fat percentage. Bioelectrical
impedance analysis has been shown to be a valid and
cost-effective measure of body composition [34]. A
Bosch PLR 30c Laser Measure (Robert Bosch GmbH,
Germany) was used to measure height.
Obstructive sleep Apnoea (OSA)
Participants were assessed for OSA using an ApneaLink™
device. The device has been shown to be a reliable and
valid method of detecting the presence and risk of OSA
in patients aged > 50 years [35]. It has a sensitivity for
AHI > 10 of 92–100% and a specificity of 87–96.7% [28,
35, 36]. OSA presence and severity was based on AHI
(normal < 5, mild 5- < 15; moderate 15- < 30 and severe
> = 30) [4, 37, 38]. Apnoea was defined as a reduction in
flow to less than 90% of normal and hypopnea as a re-
duction in flow to 30% of normal with 4% desaturation
for at least 10 s [39].
Feasibility and retention
Feasibility was assessed in relation to participant compli-
ance and adherence to the intervention. Compliance and
adherence to the intervention of at least 80% was
deemed as feasible. Participant retention was also
deemed successful at 90%.
Study procedures
Following consent, eligible participants with an AHI
score greater than 15 were invited to take part in the
intervention. Baseline data collected included: informa-
tion regarding the participant general health, anthropo-
metric measures, and current daily physical activity
levels (IPAQ).
At baseline, participants were advised in a 15-min face
to face session by the principal investigator, as to how to
increase the frequency, duration and intensity of their
current PA levels (e.g. taking the stairs instead of the lift)
over the 12 weeks (Table 1). RPE was used to gauge ap-
propriate % increase in intensity ranging from a score of
9 to a score of 16. An increase in exercise intensity from
9 to 11 on the Borg scale was deemed suitable for less
trained; this was advised at the start of the intervention
and then increased upwards as required [33, 40]. Partici-
pants were asked to report their total daily amount of
PA and intensity (RPE) as two numbers (minutes/dur-
ation of PA and number corresponding to RPE on the
Borg scale) to the mobile phone of a researcher via text
message. Levels of PA were monitored by GTX3 acceler-
ometers at three time points for 7 days (during weeks 1,
6, and 12). Participants were asked to wear the acceler-
ometer on a belt on the right hip from the moment they
got up until they went to bed. Removal of the acceler-
ometer was instructed for showering, bathing and swim-
ming. Total minimum wear time required was 12 h for
seven days [31]. At the end of each seven-day period a
researcher collected and downloaded the recorded data
from the accelerometer. The accelerometer data was
then compared to the self-report PA scores. At the end
of the 12-week period, post intervention measurements
including AHI were taken as described earlier and com-
pared to those at baseline to assess effectiveness of the
intervention.
Data analysis
Data analysis was performed using IBM SPSS Statistics
software version 25. Data are presented as mean differ-
ence scores (95% CI) and effect sizes. In addition, for
informative purposes, paired samples t-tests were
Table 1 Structure of 12-Week Physical Activity Intervention
Weeks Duration (Mins) RPE Frequency (days per week)
1–4 10–15 9 3
5–8 15–20 9–13 4
9–12 30 13 5
RPE Rate of Perceived Exertion
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performed to assess change of PA levels over time in mi-
nutes and perceived exertion (RPE) from beginning to
end of intervention. The same tests were also used to in-
vestigate change over time in AHI (OSA severity), PA,
weight and fat pre- to post-intervention. Where the as-
sumption of normality was violated for any variable, the
non-parametric Wilcoxon signed-rank test was used in-
stead. Pearson correlations were used to assess relation-
ships between continuous variables on the change scores
from pre-post intervention. Significance was assumed
where p < 0.05.
Results
Intervention selection
A total of 59 participants who responded to displayed
posters were screened for inclusion in the intervention
study. Of the original pool of participants, 49 were
excluded due to an AHI score of less than 15. Ten
eligible participants (mean age 57.3 (6.02) years, 8
males), with an AHI score greater than 15, were
recruited in the intervention. A flow diagram of screen-
ing, recruitment and intervention completion is illus-
trated in Fig. 1 below.
Baseline characteristics for all participants are
shown in Table 2. All 10 participants who were re-
cruited in the study completed the intervention, there
were no drop outs, although some missing data was
present for certain variables. Participants were
middle-aged men and women with moderate OSA
who were non-smokers, were overweight or obese
and were mostly sedentary. Their alcohol intake was
less than 14 units per week.
Primary aim analysis
All 10 participants (100%) complied with and adhered
fully to the 12-week intervention thus, the feasibility of
delivering the intervention was confirmed, although data
was missing (two participants without fat % measure-
ments and 1 each for RPE, AHI and weight).
OSA and physical activity levels
Lower levels of baseline self-reported PA (IPAQ) were
associated with higher baseline AHI score.
The impact of the intervention
The impact of the intervention is summarized in Table 3.
Analysis revealed that compared to baseline, after the
intervention there were significant improvements in PA
duration and RPE, and a trend towards an improvement
in AHI without any changes in body weight or body com-
position. The effect sizes for the change in PA and RPE
Fig. 1 Flow chart showing process of screening and recruitment
Table 2 Descriptive statistics of the sample (n = 10) at baseline.
Data presented as mean (SD)/Number (N)
N Minimum Maximum Mean Std. Deviation
BMI 10 25.00 46.00 32.9000 7.23341
Weight -Base (Kg) 10 76.00 130.00 96.6000 17.69620
Body Fat - Base 10 31.00 79.00 46.1000 15.28580
AHI - Base 10 15.00 39.00 22.6000 6.97933
ActivityMinsWk1 10 30.00 220.00 107.7000 62.60112
ActivityRPE1 10 9.00 14.00 10.5000 1.90029
Age 10 50.00 69.00 57.3000 6.01941
IPAQ – Base 10 1.00 3.00 2.0000 .47140
Valid N (listwise) 10
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are considered large, and for AHI the effect was medium.
Time spent in PA was confirmed by accelerometer in
week one with an average count of 1515, indicating light
PA, and in week 12 with an average count of 2060, indi-
cating moderate PA (Freedson et al. 1998).
Correlations between AHI change scores (pre-post) and
BMI, weight, and fat show that the trend for a reduction
in AHI was seemingly independent of the change in BMI
(r = −.51, p = .16), weight (r = −.34, p = .36), and fat (r =
.11, p = .80).
Discussion
Our study demonstrated that it is feasible to deliver a
12-week PA intervention to patients with OSA aged
above 50 years old in a community setting, and that a
structured PA program might have the potential to im-
prove PA and OSA severity independent of weight loss.
Currently, the debate relating to the mechanisms by
which PA reduces OSA severity is unresolved. Although
previous research has demonstrated that increased venti-
lator muscle tone may be key [26], others disagree [41].
Additionally, Redolfi et al., [25] demonstrated that a
decrease in fluid shift towards the neck during sleep as a
result of walking increased the space in the pharyngeal
region. Although, each of the above suggestions is
logical, more recent evidence suggests that OSA reduc-
tion might be as a result of reduced inflammation and
improved autonomic function via exercise, [41–43].
These in turn, might potentially improve chemosensitiv-
ity and upper airway stability.
The present study gives tentative support for a PA
intervention to reduce OSA. In contrast to previous
research that utilized supervised interventions, the PA
intervention in the present study was unsupervised [43–
45]. As such, the potential of unsupervised exercise to
reduce OSA might be advantageous on two counts.
Firstly, to those who find it difficult to fit scheduled
exercise into their day, and secondly promotes greater
frequency of movement over a 24-h period [46]. The
present study also demonstrates the feasibility of deliver-
ing a PA intervention to older manual workers who are
an underserved population in this area of research. In-
deed, older manual workers have been previously shown
to have low levels of leisure time PA, thus, together with
their increasing age, older workers are likely candidates
for OSA development [47–49]. Previous research into
exercise as an intervention for OSA management, has
largely used structured/planned supervised exercise, and
although indications are positive in this effect, it is un-
known as to whether participants are likely to adhere to
such structure beyond intervention end [41, 45, 50, 51].
In this respect, the present study demonstrated that it is
possible for a group of OSA sufferers aged 50 and over
to adhere to a PA intervention, however, in order to as-
sess whether the nature of the intervention would be
sustainable in the long-term requires further research.
Thus, more longitudinal studies are necessary in this re-
spect to determine this outcome. Additionally, findings
from the present study demonstrate the potential of
daily-unstructured PA to somewhat reduce OSA sever-
ity. This is encouraging, since daily general PA such as
walking or using the stairs instead of lifts, may be easier
to incorporate into daily life and therefore, more sustain-
able in the long-term, as opposed to structured exercise
which requires planning. Indeed, Chaput, Carson [46]
suggests that PA spread over a 24-h period may be more
beneficial to health than single bouts of planned
exercise.
The present study also offers support to the recom-
mendations of daily levels of PA to preserve health and
prevent disease and demonstrates that the recommended
daily activity levels for adults may be sufficient to some-
what reduce or potentially prevent OSA and its develop-
ment. Further, the contribution of regular daily PA, may
offer an alternative means of OSA management,
especially for those who find they cannot tolerate treat-
ments such as CPAP and also help to offset the risk of
CVD in OSA sufferers [52, 53]. Although the exact
mechanism by which cardiorespiratory fitness decreases
the risk of CVD is unclear, possible mechanisms such as
an improvement in arterial function and anti-
inflammatory effects have been suggested [54]. It has
also previously been suggested that regular PA may im-
prove inflammatory profiles associated with OSA and
CVD such as activation of the peripheral nervous system
and others that predispose an individual to vascular dam-
age [42]. Although CPAP is still the recommended gold
standard treatment for OSA management, it does not pro-
mote the participation of regular physical activity, which
has far reaching benefits for health and wellbeing [55].
Table 3 Changes in variables from baseline to end of intervention. Data presented as mean (SD)
Variable Baseline End Mean Difference 95% CI Hedges P value N Hedges’g (Effect size)
PA min 113.1 (64.69) 248.4 (148.31) − 135.25 − 251.7 to −18.8 −0.85 0.02 8 −1.115
RPE (effort) 10.7 (1.94) 13.8 (1.56) −3.11 −4.4 to −1.9 −1.71 0.001 9 −1.660
AHI 22.3 (7.35) 15.8 (7.48) 6.56 −1.2 to 14.3 0.56 0.09 9 0.826
Weight (kg) 98.6 (17.59) 98.7 (15.30) −0.11 −2.1 to 1.9 − 0.04 0.90 9 −0.006
Fat (%) 43.4 (10.94) 43.0 (11.56) 0.38 −3.5 to 4.2 0.07 0.67 8 0.034
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Limitations and strengths
It must be noted that the present study is not without
limitations. Firstly, the sample size was very small and
thus, findings from the present study cannot be general-
ized to other groups. Additionally, the sample was com-
posed mainly of Male vs Female and thus is a possible
biased that must be acknowledged. However, the present
study is a feasibility study and thus, may serve as a plat-
form to guide similar interventions in this age group.
Secondly, the daily PA duration and intensity across the
12 weeks were self–reported and so may be prone to re-
call bias and over-reporting. However, the PA levels
were validated at three time points across the interven-
tion with accelerometers and as such validate the re-
ported levels of PA. The present study demonstrated a
significant increase in activity levels and a trend towards
a change in OSA severity post-intervention which seems
independent of the change in BMI and weight-loss.
Further, the changes demonstrated in OSA severity
(which cannot be manipulated or influenced) suggest
that intervention PA adherence was good.
The strengths of the present study should also be
noted. To our knowledge, this is the first feasibility study
into this group of participants that has used unstruc-
tured general PA to reduce OSA. Additionally, all of the
participants were older workers, aged 50 years and over
who were not undergoing any treatment for OSA.
Conclusions
A 12-week PA intervention using general daily PA can
be delivered and adhered to adults aged 50 years and
over with OSA. PA reduced OSA severity somewhat and
independent of weight-loss and BMI. This suggests that
incorporating more general activity during daily life may
prove a feasible route to the management of OSA, and
as such warrants examination in full RCT.
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